Iovance Biotherapeutics, Inc. (2LB)
Market Closed
3 Jun, 20:00
€
3. 4800
+0.06
+1.75%
€
- Market Cap
- P/E Ratio
- Div Yield
1,000 Volume
-1.87 Eps
€ 3.42
Previous Close Want to track 2LB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
2LB Earnings Reports FAQ
What is the earnings per share (EPS) for 2LB?
The current EPS is -1.87.
What is the company's earnings growth rate?
Iovance Biotherapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Iovance Biotherapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Iovance Biotherapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 2LB at this time, as Iovance Biotherapeutics, Inc has no recent EPS data to calculate it.
